阿托伐他汀调脂治疗对冠心病合并代谢综合征患者血脂水平及心脑血（基础医学范文）.docVIP

阿托伐他汀调脂治疗对冠心病合并代谢综合征患者血脂水平及心脑血（基础医学范文） 文档信息 属性： F-00P9ED，doc格式，正文6299字。质优实惠，欢迎下载！ 适用： 作为文章写作的参考文献，解决如何写好实用应用文、正确编写文案格式、内容摘取等相关工作。 作者： 佚名 目录 TOC \o 1-9 \h \z \u 目录 1 正文 1 搞要 1 关键字：阿托伐他汀； 冠心病； 代谢综合征； 血脂； 心脑血管事件 2 1 资料与方法 3 2 结果 5 3 讨论 5 参考文献 6 论文原创声明（模板） 9 论文致谢（模板） 9 正文 阿托伐他汀调脂治疗对冠心病合并代谢综合征患者血脂水平及心脑血（基础医学范文） 搞要 摘要：目的：探讨分析阿托伐他汀调脂治疗对冠心病合并代谢综合征患者血脂水平及心脑血管事件发生率的影响。方法：从2015年8月-2016年8月本院收治的冠心病合并代谢综合征患者中采取数字随机法抽取100例进行观察（观察组），并抽取同期收治的单纯冠心病血脂异常患者100例（对照组），所有患者均使用阿托伐他汀进行调脂，比较两组治疗后血脂水平变化及心脑血管发生率。结果：治疗前两组TC、LDL-C、ApoA1及ApoB-100水平比较，差异均无统计学意义（P），观察组TG、HDL-C水平比对照组均显著更高（）；在心脑血管事件发生率上比较，观察组显著高于对照组（P）。结论：冠心病合并代谢综合征患者使用阿托伐他汀治疗后不能达到理想的血脂水平，仍存在高TG、低HDL-C的血脂特点，且使用阿托伐他汀治疗后并不能控制该类患者心脑血管事件的发生 关键字：阿托伐他汀； 冠心病； 代谢综合征； 血脂； 心脑血管事件 【Abstract】 Objective：To probe into and analyze the influence of Atorvastatin lipid-lowering therapy for level of blood lipid and the incidence of cardio cerebrovascular events in patients with coronary heart disease complicated with metabolic ：100 cases of patients with coronary heart disease complicated with metabolic syndrome and who accepted treatments in our hospital from August 2015 to August 2016 were selected by digital random method as the observation group，while other 100 cases of coronary heart disease patients with dyslipidemia were selected as the control patients were treated with Atorvastatin lipid-lowering ，the changes of blood lipid levels and the incidence rate of cardiovascular and cerebrovascular diseases of two groups after the treatment were ：There were no significant differences in the levels of TC，LDL-C，ApoA1 and ApoB-100 between two groups before treatment（P），while the levels of TG and HDL-C of the observation group were significantly higher than those of the control group（）.The incidence of cardio cerebrovascular events were compared，the observation group was significantly higher than that of the control group（P）.Conclusion：The patients with coronary heart disease complicated with metabolic syndrome do not achiev